Real-world Effectiveness of Nirmatrelvir-Ritonavir in Reducing Severe COVID-19 Outcomes by Age Groups in Canada

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

https://idweek2026.eventscribe.net/fsPopup.asp?PosterID=837933&mode=posterInfo

Maria Major, PhD; Natalie Nightingale, MSc; Jen Belcher, PharmD; Irene Wang, MSc; Calum S. Neish, PhD; Jean-Christophe Simard, PhD; Laura A. Puzniak, PhD. MPH

Sep 6, 2026